TNF and type 2 diabetes mellitus: Confirming these results, other studies have shown that subclinical systemic inflammation in obese patients, as measured by elevated levels of CRP, IL-6, and TNF-α, predicts the development of type 2 diabetes [87,88] and contributes to a decrease of insulin sensitivity in peripheral tissues [89].